Showing 321-330 of 10578 results for "".
Imagining Healthcare's Future: The Emergence of TEDMED
https://reachmd.com/programs/your-career-in-healthcare/imagining-healthcares-future-the-emergence-of-tedmed/6635/TEDMED is a community of people who are passionate about imagining the future of health and medicine. Once a year, the organization holds a "grand gathering" where leaders from all sectors of society come together for three and a half days. They explore the promise of technology and the potential ofCases From the Real World: 65-Year-Old Woman With DME and Considering Cataract Surgery
https://reachmd.com/programs/cme/Cases-From-the-Real-World-65-Year-Old-Woman-With-DME-and-Considering-Cataract-Surgery/33173/Join our faculty as they explore managing patients with DME who are considering cataract surgery with second-generation retinal agents.Patient-Centric ADT Intensification in Hormone-Sensitive Prostate Cancer: Balancing Efficacy, Safety, Quality of Life, and Survival
https://reachmd.com/programs/cme/patient-centric-adt-intensification-in-hormone-sensitive-prostate-cancer-balancing-efficacy-safety-quality-of-life-and-survival/27147/This education will help clinicians develop evidence-based and collaborative treatment plans for the management of hormone-sensitive prostate cancer (HSPC) with ADT intensification, leading to improved outcomes, reduced riEpilepsy Essentials: The Current and Future Landscape of Tuberous Sclerosis Complex Diagnosis and Treatment
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-the-current-and-future-landscape-of-tuberous-sclerosis-complex-diagnosis-and-treatment/32157/Prenatal diagnosis, genetic testing, and mTOR inhibitors have fundamentally transformed the treatment of tuberous sclerosis complex in the neurology clinic.Utility of Stereoelectroencephalography in the Treatment of Drug-Resistant Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/utility-of-stereo-electroencephalography-in-the-treatment-of-drug-resistant-epilepsy/48919/Drug-resistant epilepsy, which affects about a third of people with epilepsy, can be effectively treated with epilepsy surgery, leading to seizure freedom in appropriately selected individuals.Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://reachmd.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
https://reachmd.com/programs/cme/secondary-hyperparathyroidism-a-hidden-danger-in-chronic-kidney-disease/14973/How can you diagnose patients with SHPT earlier in CKD and control PTH levels early in the disease course? Our experts have what you need to know!Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
https://reachmd.com/programs/cme/insights-from-global-key-opinion-leaders-on-regional-regulatory-and-guideline-nuances-to-optimize-melanoma-management/36331/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Innovations in Oncology Learning Center: From Guidelines to Practice: Melanoma
https://reachmd.com/programs/cme/innovations-in-oncology-learning-center-from-guidelines-to-practice-melanoma/33212/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
https://reachmd.com/programs/cme/no-patient-with-ckd-left-behind-emerging-ckd-therapies-in-t1d/36524/Gain insights in CKD screening practices, pathophysiology, and treatment from the results of the FINE-1 trial evaluating finerenone in patients with type 1 diabetes.